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ABSTRACT
JO ANN GALLOWAY: The Synthesis and Characterization of Ionic Liquids using NitrogenBased Cations for Transdermal Delivery (Under the direction of Dr. Eden Tanner)
The purpose of this research was to explore the synthesis mechanisms of water-soluble
ionic liquids with nitrogen-containing cationic bases for future use in transdermal drug delivery
and forensic science applications. Ionic liquids are salts with an organic cation and either an
organic or inorganic anion. They have asymmetric structures, which means that the molecules
don’t pack together as neatly as other salts do, therefore, they don’t crystallize as easily, and their
melting points are lower. Ionic liquids have melting points below 100°C, and many are liquid at
room temperature. Mechanistic studies reveal that the potency of ILs in enhancing transdermal
drug delivery correlates inversely with the inter-ionic interactions as determined by 2D 1H Nuclear
Magnetic Resonance spectroscopy. After performing porcine skin test trials with choline trans-2hexenoate and choline trans-2-octenoate, it was determined 2-octenoic acid was the best anionic
candidate for further IL synthesis in regards to transport through porcine skin. Chemical
interactions and organic processes and methods were used in the synthesis of seven new ionic
liquids: (1:2) choline:3-pentenoate, (1:2) choline:trans-2-hexenoate, (1:2) choline:2-octenoate,
(1:2) 1-methylimidazolium:2-octenoate, (1:2) 1-methylpyrrolidinium:2-octenoate, (1:2)
pyridinium:2-octenoate, and (1:2) 4-methylmorpholinium:2-octenoate. Ionic liquids are of
growing interest in the scientific community due to the vast range of physicochemical properties
that can be accessed through specific tailoring of the cationic or anionic constituents of the ionic
liquid. Choline-based ILs, specifically, have been used to enhance the transdermal delivery of
several small and large molecules; however, research into different nitrogen-cationic containing
ILs is significantly lacking in the literature. Overall, this research provides a generalized
framework for optimizing ionic liquid synthesis for enhancing skin permeability in the hopes that
transdermal delivery of drugs will be a viable, non-toxic, and noninvasive option for the future of
medicine.
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PREFACE
The general outline for this research includes discussion on ionic liquid synthesis, transdermal
delivery using pig skin test trials, the instrumentation and application of Nuclear Magnetic
Resonance (NMR) spectroscopy, sampling and data obtained from NMR spectroscopy, and the
use of ionic liquids in forensic applications. The major objectives for this research were to
determine the proper settings, chemicals, solvents, instrumentation, and temperatures for chemical
reactions to occur in the synthesis of seven new ionic liquids. NMR spectroscopy was used to
confirm the proper reactions occurred throughout experimentation, and that the correct ionic
liquids had been synthesized.
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Introduction
Ionic Liquids (ILs) are gaining widespread recognition as novel solvents in many fields
including forensic chemistry, electrochemistry, bioanalytical chemistry, biology, and medicine.
ILs are composed of large asymmetric organic cations and inorganic or organic anions and are
liquid < 100 °C (23). ILs are generally colorless liquids with relatively high viscosities and
negligible vapor pressures under ambient conditions, thus they are effectively considered nonvolatile solvents (31). Some properties, such as the thermal stability and miscibility, mainly depend
on the anionic component of the IL, while others such as viscosity, surface tension, and density
depend on the alkyl chain in the cationic component and/or the shape or symmetry of the cation
(31). Furthermore, strong interactions between the anions and cations involved in IL synthesis are
essential to the formation of stable ILs. The most prominent cations used in ILs today include
pyridinium and imidazolium ring species with one or more alkyl groups attached to the nitrogen
atoms (26). Figure 4 shows common base structures for IL cations, namely imidazole, pyridine,
pyrrolidine, and morpholine. In addition to traditional chemical interactions that exist in
conventional organic solvents, ILs also have ionic interactions which makes them very miscible
with polar substances. Changing the precise chemical composition of the cationic and anionic
components of ILs significantly changes characteristics such as solubility, viscosity,
hydrophobicity, and many others (31). This research examines the effects of tailoring the cationic
component of carboxylic acid-based ILs for further investigation in transdermal drug delivery.

Figure 1 - Example structures of generic task-specific ionic liquids (26).
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Deep eutectic solvents are materials that, once combined, experience depression in the melting
point due to the formation of hydrogen bonds (30). ILs are considered deep eutectic solvents.
Furthermore, they are composed of bulky and asymmetric organic anions and cations that exist as
liquids below 100°C. ILs express a number of properties that make them desirable for use in
biomedical applications and drug delivery (30). In biomedical applications, ILs are used to
solubilize drugs (19), create active pharmaceutical ingredients (19), facilitate the delivery of
pharmaceuticals through biological barriers (29), and stabilize proteins and their nucleic acids (13).
The human body contains complex defense systems in order to prevent the entrance of toxins and
other foreign pathogens. These complex defense systems also restrict effective drug delivery. In
recent years, IL research has shown promising techniques for navigating cell membranes and other
biological barriers (30). ILs, specifically, have been effective at penetrating skin. The efficiency
of ILs in enhancing dermal permeability was expected to depend on their ionic composition and
counter-parts. However, mechanistic studies have revealed that the efficiency of ILs in enhancing
transdermal drug delivery correlates inversely with the inter-ionic interactions as determined by
1H NMR spectroscopy (30). Recently, ILs have been conjugated with polymers to create delivery
systems. Chemical modifications in the anionic component revealed ILs with the fewest inter-ionic
interactions to be the most successful at transdermal permeability. Furthermore, modifications of
the cationic component can maximally reduce the inter-ionic interactions thus furthering
enhancement in drug delivery efficacy (30).
The most common routes of drug delivery are the oral, intravenous, and parenteral routes
(19). Although each route of drug delivery consists of both its positive aspects and fair share of
limitations, the limitations with conventional routes of medication delivery could potentially be
overcome by alternative drug delivery methodologies such as transdermal drug delivery (TDD).
TDD is a painless method of delivering drugs systemically by applying a drug formulation onto
intact and healthy skin (29). The skin is the most accessible and largest organ of the body,
comprising roughly 16% of the total body mass of an average person (30). Porcine skin has striking
similarities to human skin with respect to its generality in regards to layers, general structure,
thickness, hair follicle content, pigmentation, collagen and lipid composition (29). The main
function of the skin is to provide a protective barrier between the body and the external
environment against microorganisms, the permeation of ultraviolet radiation, chemicals, allergens
and the loss of water (29). Skin can be divided into three main regions: (1) the outermost layer, the
epidermis, which contains the stratum corneum; (2) the middle layer, the dermis and (3) the
innermost layer, the hypodermis (Figure 2). The other cells, which comprise less than 5% of the
skin, are the Merkel receptor cells, the melanocytes, and the Langerhans cells, a type of dendritic
cell (DC) typically associated with the skin (29). Because of the absence of blood vessels in the
epidermis, the tissue receives nutrients and oxygen supply by diffusion from dermal blood vessels.
In TDD, the drug initially penetrates through the stratum corneum and then passes through
the deeper epidermis and dermis. When a drug reaches the dermal layer, it becomes available for
12

systemic absorption via the dermal microcirculation (22). TDD has many advantages over other
conventional routes of drug delivery; it can provide a non-invasive alternative to parenteral routes,
thus circumventing issues such as needle phobia. A large surface area of skin and ease of access
allows for many placement options on the skin for transdermal absorption. Furthermore, the
pharmacokinetic profiles of drugs are more uniform with fewer peaks, thus minimizing the risk of
toxic side effects (22). Lastly, TDD avoids pre-systemic metabolism, thus improving
bioavailability (22).

Figure 2 - Anatomy of the Skin.

There are two possible routes of drug penetration across the intact skin; the transepidermal
and transappendageal pathways (8). Both can be seen in figure 3. The transepidermal pathway
involves the passage of molecules through the stratum corneum, a diverse, multi-layered and multicellular barrier. Transepidermal penetration can be termed intra- or inter-cellular (8). The
intracellular route through corneocytes, terminally differentiated keratinocytes, allows the
transport of hydrophilic or polar solutes. Transport via intercellular spaces allows diffusion of
lipophilic or non-polar solutes through the continuous lipid matrix. The transappendageal route
involves the passage of molecules through sweat glands and across the hair follicles (8).
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Figure 3 - Drug Penetration Routes across Human Skin.

Pharmaceutical industries face a series of challenges in the delivery of many newly
developed active pharmaceutical ingredients (APIs) because of their low solubility, bioavailability,
stability and high degree of polymorphic conversion (19). ILs have started being used as solvents
and cosolvents of APIs which has led to promising results in antioxidants, anti-tumoral, and
antimicrobial activities of drug compounds and derivatives (19). The use of ILs as alternative
solvents and cosolvents for APIs was first introduced in 2008. Imidazolium-based ILs were used
to solubilize potassium penicillin V, dexamethasone, dehydroepiandrosterone, and progesterone
(19). In comparing ILs to their water solubility, it was found that imidazolium-based ILs enhance
solubility by several orders of magnitude specifically for antifungal, analgesic, non-steroidal antiinflammatory, and anti-cancer drugs. Proper selection of hydrophilic-lipophilic cations and anions
for ILs enables the tailoring of both drug delivery systems and solubilization molecules to enhance
the solubility of APIs in different pharmacological classes (19).
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Figure 4 - Applications of Ionic Liquids in the Design and Development of Drug Delivery Systems.

Further applications of ILs in drug delivery involve the tuning and slowing of the release
profile of stimuli-responsive systems in the body. Cholinium-based ILs have been studied to
examine a more controlled release of traditional ionic drugs (19). This is due to the chemical
conductivity displayed by ILs. Choline-based ILs, in particular, have been used to enhance the
transdermal delivery of several small and large molecules. Kinetic studies have shown that,
regardless of the pH in the release medium, traditional APIs released from film loads are released
slower than traditional APIs loaded with ILs thus showing a direct correlation between the
presence of IL and release rate (19). Overall, the use of ILs as permeability enhancers as well as
components of micro-emulsions has improved both the topical and transdermal delivery of several
drugs thus allowing for higher levels of permeability, solubility, and bioavailability across
biological membranes (19). This information is the basis for the research performed in this report.

Visible solvent effects of ILs include solubility, stability, viscosity, hygroscopy, and permeability.
In order to understand such solvent effects from changing a reagent to a final IL product, it is
necessary to examine representative reactions. The main reaction occurring throughout the
synthesis of these seven ILs is a salt metathesis reaction, also known as a double displacement
reaction. Salt metathesis reactions are a type of chemical reaction where bonds or ions are
exchanged between two interacting species (25). Salt metathesis reactions result in a product with
similar bonding properties as the starting reagents. The following reaction scheme is representative
of a typical salt metathesis reaction:
AX + BY → BX + AY.
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The following chemical properties and IL characteristics were examined during the formation and
synthesis of these seven ILs: delocalization of the molecule within a five-carbon ring structure, a
five-carbon ring structure without delocalization or double bonds, aromaticity in the cationic
molecule, and oxygenation of a nitrogen containing cyclohexane cyclic ring. The cationic
components selected to examine each previously listed chemical property above include methylimidazolium, methyl-pyrrolidinium, pyridine, and methyl-morpholinium respectively. Because
both the cationic and anionic components can be changed in IL synthesis, ILs have been used as
alternative methods to traditional molecular solvents (23). Given the previously listed information,
the primary aim of this research was to consider and examine the effects of modifying the cationic
component of an IL on the outcome of the chemical reactions occurring, and correlate this to
dermal penetration through transdermal delivery of porcine skin. This was performed through a
series of different synthesis mechanisms, thus allowing the determination of the requirements of
the IL necessary to aid the key chemical interactions involved.

Figure 5 - Starting materials for the cationic components of Ionic Liquids synthesized. From left to right:
1-methylimidazolium, pyridine, 1-methylpyrrolidinium, and 1-methylmorpholine.

Figure 6 - Choline Bicarbonate cationic starting material for three synthesis reactions.
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Figure 7 - Anionic components of Ionic Liquids synthesized. From left to right: 3-Pentenoic acid, Trans-2Hexenoic acid, and 2-Octenoic acid.

Chapter 1: Experimental
Materials and Safety
Before experimentation could begin, safety concerns were taken into consideration for all
chemicals involved. In order to protect against contact with the chemicals, personal protective
equipment such as a lab coat, pants, nitrile gloves, protective eyewear, and close-toed shoes were
worn at all times in the laboratory. In conducting this research, I avoided breathing any dust, fumes,
gas, mist, vapors, or spray from any chemicals involved. The protocols for coming in contact with
a chemical include washing skin thoroughly after handling, using only a well-ventilated area or
hood, wearing protective gloves, eye protection, and face protection. For any chemicals involved,
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if in contact with the skin, it was imperative to wash with plenty of detergent and water. For any
chemicals involved, if inhaled, it was imperative to remove the victim to fresh air and keep at rest
in a position comfortable for breathing. For any chemicals involved, if in contact with the eyes, it
was imperative to rinse cautiously with water for several minutes, remove any contact lenses if
present and easy to do, and continue rinsing until thorough flushing had been achieved.
All reagents used were of analytical grade and were used without further purification. All
chemicals and reagents used throughout synthesis came from Sigma-Aldrich Co. made in the USA.
SIGMA-ALDRICH, Co. 3050 Spruce Street, St. Louis, MO 63103 USA. All Porcine Skin used
throughout experimentation was obtained from Smokehouse Meats in Pontotoc, Mississippi.
Acetone (C3H6O) packaged under Nitrogen and Submicron filtered with a molecular weight of
58.08 g/mol. Acetone is a highly flammable liquid and vapor. It can cause serious eye irritation
and may cause drowsiness or dizziness. It can further cause damage to organs through prolonged
or repeated exposure.
Acetonitrile (C2H3N) suitable for HPLC, gradient grade >99.9% with a molecular weight of 41.05
g/mol. Acetonitrile is a highly flammable liquid and vapor. It is harmful if ingested or swallowed,
comes in contact with skin, or if inhaled. It can cause serious eye irritation and should be stored
far from heat, hot surfaces, sparks, or other ignition sources.
Methanol (CH4O) Anhydrous 99.8% with a molecular weight of 32.04 g/mol. Methanol is a highly
flammable liquid and vapor. It is toxic if swallowed, in contact with skin, or inhaled. It further
causes serious damage to organs such as the eyes.
Ethyl alcohol (C2H6O) purified, 200 proof, anhydrous >99.5% with a molecular weight of 46.07
g/mol. Ethyl alcohol is a highly flammable liquid and vapor. It causes serious eye irritation and is
best to keep from heat or hot surfaces.
Choline bicarbonate (C6H15NO4) ~80% H2O with a molecular weight 165.19 g/mol stored at 2-8°C.
Choline bicarbonate can cause skin and eye irritation, as well as potential respiratory irritation.
Choline Bicarbonate is relatively one of the safer chemicals used throughout experimentation, but
personal protective equipment and safety precautions are still necessary during use.
1-methylimidazole (C4H6N2) purified by redistillation >99% with a molecular weight of 82.10
g/mol. 1-methylimidazole is considered a very hazardous skin and eye irritant. It is also slightly
corrosive so inhalation or ingestion of the chemical should be avoided.
2-chloroethanol (C2H5ClO) 99% purified with a molecular weight of 80.51 g/mol. 2-chloroethanol
18

is considered a poison inhalation hazard, and fatal if inhaled, swallowed, or absorbed through the
skin. It is sensitive to moisture and should be stored in dry locations. Overexposure can cause
irritation and edema of eyes, mucous membranes, the respiratory tract, and skin. Prolonged
exposure causes tissue destruction, chemical burns, and residual scarring.
3-pentenoic acid (C5H8O2) mainly present in the trans form (>90% GC), purified >95.0% (sum of
isomers, GC) with a molecular weight of 100.12 g/mol. 3-Pentenoic acid is of concern because it
is a skin irritator, and it can be corrosive and cause severe burns or damage. 3-pentenoic acid may
be corrosive to metals especially, and may cause severe skin burns and eye damage.
Trans-2-hexenoic acid (C6H10O2) purified >98.0% FG with a molecular mass of 114.14 g/mol.
Trans-2-Hexenoic acid is considered corrosive and a skin/eye irritator. It causes severe skin burns
and eye damage and serious eye damage.
2-octenoic acid (C8H14O2) technical grade 85%, repurified with acetone washing approximately 3
times, with a molecular weight of 142.20 g/mol. 2-octenoic acid is considered a danger because it
is corrosive. It causes severe skin burns and eye damage and causes serious eye damage. It is a
danger of skin corrosion/irritation and serious eye damage/eye irritation.
1-methylpyrrolidine (C5H11N) >98.0% purified (GC) with a molecular weight of 85.15 g/mol. Nmethylpyrrolidine is classified as flammable, corrosive, and an irritant. It is a highly flammable
liquid and vapor. It is harmful if swallowed and can cause acute toxicity through oral ingestion. It
also causes severe skin burns and eye damage so it is a danger for skin corrosion and irritation.
Pyridine (C5H5M) ACS Reagent >99.0% with a molecular weight of 79.10 g/mol. Pyridine is
considered flammable and an irritant. It is a highly flammable liquid and vapor. It is harmful if
swallowed and can cause acute oral toxicity. It is harmful if in contact with skin and risks acute
dermal toxicity. Lastly, it is harmful if inhaled and can lead to acute respiratory toxicity if inhaled.
Potassium carbonate (CK2O3) BioXtra purified >99.0% with a molecular weight of 138.21 g/mol.
Potassium carbonate causes skin and serious eye irritation. It may also cause respiratory irritation
if exposed for prolonged periods of time.
Potassium bicarbonate (CHKO3) BioUltra purified >99.5% (T) with a molecular weight of 100.12
g/mol. Potassium Bicarbonate is known as an irritant. It causes skin irritation and serious eye
irritation. It may also cause respiratory tract irritation and risks specific target organ toxicity under
single exposure.
4-methylmorpholine (C5H11NO) purified by redistillation >99.5% with a molecular weight of
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101.15 g/mol. 4-methylmorpholine is considered flammable, corrosive, and an irritant. It is a
highly flammable liquid and vapor, and it is harmful if swallowed thus it risks acute oral toxicity.
It causes severe skin burns and eye damage or irritation. It is harmful in contact with skin or if
inhaled because it risks acute dermal or inhalation toxicity.

Methods
IL Synthesis
The primary goal of this research was to investigate the methods required to synthesize different
ILs with varying cationic and anionic components for future use in transdermal delivery since
different tailored components yield noticeably different physical and chemical properties of ILs.
Many instruments and instrumental techniques were employed throughout the entirety of
experimentation; however, most general equipment remained constant for each new IL, while
different chemicals, masses, and temperatures were used. Necessary equipment for synthesis
includes: Round Bottom Flasks (100 mL or 500 mL), hotplate with stirring and heating capability,
magnetic stir bars, a rotary-evaporator, a thermometer, a retort/clamp stand with clamp, an oil bath,
an analytical balance, Sigma Aldrich purification grade cationic and anionic components, beakers,
glass Pasteur pipettes, milli-Q water, glass scintillation vials, a vacuum oven, and a Karl Fischer
titration instrument. Molar masses of each compound were used for calculations in determining
how much of each substance was necessary for each step. A 400-Hz NMR spectrometer was used
to confirm all reactions took place in the manner they were intended to. An NMR spectrum was
obtained for each IL after every new step of synthesis for quality assurance purposes.

[1CA:3PE] - (1:2) Choline 3-Pentenoate Synthesis

Figure 8 - Chemical reactions in the synthesis of [1CA:3PE].
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An oil bath was heated to approximately 60°C and the stirrer on the hot plate was adjusted
to 410 RPM. 3.5022g of 3-Pentenoic acid (MW: 100.12g/mol) were weighed and placed in a 500
mL RBF. 3.6254g of Choline Bicarbonate (MW: 165.19g/mol) were weighed and added to the
RBF in a drop-wise manner using a glass Pasteur pipette. Less than 1 mL of milli-Q water was
used to rinse the master pipette and weighing materials, the milli-Q was then added to the RBF.
The mixture was left stirring on heat overnight for approximately 24 hours. The mixture was then
placed on the rotary-evaporator and set to 15 mbar for just over 1 hour in order to evaporate any
remaining solvents. The mass of the final product was weighed and noted; 4.5891g of [1CA:3PE]
were obtained. The solution was then placed in the vacuum oven set at 60°C for over 48 hours
with the top left off. Time sensitivity during this step was not as imperative as other steps since
the purpose of this step was to dry out any remaining solvents or water in the IL. Once removed
from the vacuum oven, the solution was reweighed and an NMR was obtained for characterization
purposes. The final mass of [1CA:3PE] being 4.4934g, resulting in a total percent yield of 86.74%.
1

H NMR (400 MHz, DMSO) δ 9.47 (s, 1H), 5.52 (dtd, J = 14.0, 7.0, 1.8 Hz, 2H), 5.37 (dq, J =
13.3, 6.3 Hz, 2H), 3.84 (dq, J = 5.8, 2.7 Hz, 2H), 3.44 (dd, J = 6.1, 3.9 Hz, 2H), 3.14 (s, 9H), 2.80
(d, J = 7.0 Hz, 4H), 1.61 (dd, J = 6.4, 1.8 Hz, 6H).

[1CA:2HE] - (1:2) Choline Trans-2-Hexenoate Synthesis

Figure 9 - Chemical reactions in the synthesis of [1CA:2HE].

An oil bath was heated to approximately 60°C and the stirrer on the hot plate was adjusted
to 400 RPM. 11.215g of Trans-2-Hexenoic acid (MW: 114.14g/mol) were weighed and placed in
a 500 mL RBF. 10.9512g of Choline Bicarbonate (MW: 165.19 g/mol) were weighed and added
to the RBF in a drop-wise manner using a glass Pasteur pipette. Less than 1 mL of milli-Q water
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was used to rinse the master pipette and weighing materials, the milli-Q was then added to the
RBF. The mixture was left stirring on heat overnight for approximately 24 hours. The mixture was
then placed on the rotary-evaporator instrument and set to 15 mbar for just over 1 hour in order to
evaporate any remaining solvents in the solution. The mass of the final product was weighed and
noted; 14.7072g of [1CA:2HE] were obtained. The solution was then placed in the vacuum oven
set at 60°C for over 48 hours with the top left off. Time sensitivity during this step was not as
imperative as other steps since the purpose of this step was to dry out any remaining solvents or
water in the IL. Once removed from the vacuum oven, the solution was reweighed and an NMR
was obtained for characterization purposes. The final mass of [1CA:2HE] being 14.587g, resulting
in a total percent yield of 101.13%. 1H NMR (400 MHz, DMSO) δ 8.88 (s, 1H), 6.38 (dt, J = 15.6,
7.0 Hz, 2H), 5.59 (dt, J = 15.5, 1.6 Hz, 2H), 3.73 – 3.64 (m, 2H), 3.33 – 3.26 (m, 2H), 2.98 (s, 9H),
1.88 (qd, J = 7.1, 1.5 Hz, 4H), 1.21 (h, J = 7.3 Hz, 4H), 0.69 (t, J = 7.4 Hz, 6H).

[1CA:2OC]

-

(1:2)

Choline

2-Octenoate

Synthesis

Figure 10 - Chemical reactions in the synthesis of [1CA:2OC].

An oil bath was heated to approximately 60°C and the stirrer on the hot plate was adjusted
to 410 RPM. 3.6604g of 2-Octenoic Acid (MW: 142.20g/mol) were weighed and placed in a 500
mL RBF. 2.8596g of Choline Bicarbonate (MW: 165.19 g/mol) were weighed and added to the
RBF in a drop-wise manner using a glass Pasteur pipette. Less than 1 mL of milli-Q water was
used to rinse the master pipette and weighing materials, the milli-Q was then added to the RBF.
The mixture was left stirring on heat overnight for approximately 24 hours. The mixture was then
placed on the rotary-evaporator instrument and set to 15 mbar for just over 1 hour in order to
evaporate any remaining solvents in the solution. The mass of the final product was weighed and
noted; 2.2688g of [1CA:2OC] were obtained. It is important to note that the solution was very
viscous, thus a lot of solution was lost in the RBF during transferring from RBF to a storage
container. The solution was then placed in the vacuum oven set at 60°C for over 48 hours with the
top left off. Time sensitivity during this step was not as imperative as other steps since the purpose
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of this step was to dry out any remaining solvents or water in the IL. Once removed from the
vacuum oven, the solution was reweighed and an NMR was obtained for characterization purposes.
The final mass of [1CA:2OC] being 2.2588g, resulting in a total percent yield of 47.50%. 1H NMR
(400 MHz, DMSO) δ 6.53 (dtd, J = 14.9, 6.9, 3.4 Hz, 2H), 5.74 (d, J = 15.5 Hz, 2H), 3.85 (dq, J =
5.7, 2.7 Hz, 2H), 3.44 (dt, J = 6.4, 3.7 Hz, 9H), 2.07 (q, J = 7.1 Hz, 4H), 1.37 (p, J = 7.2 Hz, 8H),
1.27 (tp, J = 7.7, 4.3, 3.4 Hz, 4H), 0.86 (t, J = 6.8 Hz, 6H).

[1MEIM:2OC] - (1:2) 1-methylimidazolium 2-Octenoate Synthesis

Figure 11 - Chemical reactions in the synthesis of [1MEIM:2OC].

An oil bath was heated to approximately 70°C and the stirrer on the hot plate was adjusted
to 270 RPM. 23.7175 g of 1-methylimidazole (MW: 82.10 g/mol) were weighed and placed in a
500 mL 3-mouthed RBF. 24.1251 g of 2-Chloroethanol (MW: 80.51 g/mol) were weighed and
added to the RBF in a drop-wise manner using a glass pasteur pipette. Less than 1 mL of milli-Q
water was used to rinse the pasteur pipette and weighing materials, the milli-Q was then added to
the RBF. For this reaction, a condenser was hooked up and nitrogen (N2) gas was flowing
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throughout the RBF and condenser thus facilitating the reaction. The mixture was left stirring on
heat, under the condenser and nitrogen gas for approximately 48 hours. After 48 hours, the heat
and N2 gas was removed, and the solution was rinsed and vacuum filtered with approximately 200
mL of diethyl ether and 50 mL of acetone. Scintillation vials were pre-weighed in order to store
the 1-methyl ethyl imidazolium, and 20.64g of solution were obtained. Molar masses for 1methylethoxyimidzaolium (MW: 162.61 g/mol) and K2CO3 (MW: 138.205) were used to calculate
the amount of Potassium Carbonate necessary for the next steps of synthesis. An NMR sample
was also obtained to confirm the correct synthesis occurred. 14.3597 g of K2CO3 was added to a
500 mL RBF with 16.7164g of 1-methyl ethyl imidazolium. The reaction was left to stir on heat
at 40°C for 30 minutes. 40 mL of methanol was added to the RBF for stirring purposes. Vacuum
filtration was used again to filter out and discard the solid KCl waste in order to obtain pure 1methylimidazolium bicarbonate. A new NMR was obtained in order to confirm proper synthesis
occurred before moving on to future synthesis steps. Again, molar masses for 1methylimidazolium bicarbonate (MW: 162.61 g/mol) and 2-Octenoic acid (MW: 142.20 g/mol)
were used in a (1:2) ratio in order to determine how much of each component to combine. A hot
oil bath was heated to 55°C and the stir plate was set to 400 RPM. 3.8079 g of 2-Octenoic acid
were added to a 500 mL RBF, then 2.6382 g of 1-methylimidazolium bicarbonate were added
dropwise to the RBF. Less than 1 mL of milli-Q water was used to rinse the master pipette and
weighing materials, the milli-Q was then added to the RBF. The reaction was left to stir on heat
overnight for approximately 24 hours. After 24 hours, the reaction was taken off heat and stir. The
mixture was then placed on the rotary-evaporator and set to 15 mbar for just over 1 hour in order
to evaporate any remaining solvents in the solution. The mass of the final product was weighed
and noted; 3.5361g of [1MEIM:2OC] were obtained. The solution was then placed in the vacuum
oven set at 60°C for over 48 hours with the top left off. Time sensitivity during this step was not
as imperative as other steps since the purpose of this step was to dry out any remaining solvents
or water in the IL. Once removed from the vacuum oven, the solution was reweighed and an NMR
was obtained for characterization purposes. The final mass of [1MEIM:2OC] being 3.4923g,
resulting in a total percent yield of 64.67%. 1H NMR (400 MHz, DMSO) δ 9.32 (s, 1H), 7.81 –
7.72 (m, 2H), 6.71 (dt, J = 14.7, 7.0 Hz, 2H), 5.76 (d, J = 15.5 Hz, 2H), 4.26 (t, J = 5.0 Hz, 2H),
3.87 (d, J = 7.6 Hz, 3H), 3.71 (t, J = 5.0 Hz, 2H), 2.69 (d, J = 7.0 Hz, 1H), 2.12 (q, J = 7.2 Hz, 4H),
1.79 (q, J = 7.2 Hz, 1H), 1.38 (p, J = 7.2 Hz, 4H), 1.34 – 1.16 (m, 12H), 0.83 (dt, J = 13.8, 6.5 Hz,
6H).
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[1MEPY:2OC] - (1:2) 1-methylpyrrolidine 2-Octenoate Synthesis

Figure 12 - Chemical reactions in the synthesis of [1MEPY:2OC].

An oil bath was heated to approximately 80°C and the stirrer on the hot plate was adjusted
to 300 RPM. 25.0619 g of 1-methylpyrrolidine (MW: 85.15 g/mol) were weighed and placed in a
500 mL 3-mouthed RBF. 10 mL of dry acetonitrile was added to the RBF and used to rinse the
pasteur pipette and weighing materials. 27.3653 g of 2-Chloroethanol (MW: 80.51 g/mol) were
weighed and added to the RBF in a drop-wise manner using the glass pasteur pipette roughly 20
minutes after the other materials. For this reaction, a condenser was attached to one opening of the
RBF while a gas ventilator was attached to the other opening. The mixture was left stirring on heat,
under the condenser and for approximately 72 hours. After 72 hours, the heat was removed and
the solution was rinsed with 20 mL of acetone five times. Vacuum filtration was used to collect
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the 1-methylethoxypyrrolidinium which was then placed on the rotary evaporator set to 15 mbar
for 1 hour. Scint vials were pre weighed in order to store the 1-methylethoxypyrrolidinium, and
27.2104g of solution were obtained. An NMR sample was also obtained to confirm the correct
synthesis occurred. Molar masses for 1-methylethoxypyrrolidinium (MW: 149.6398 g/mol) and
K2CO3 (MW: 138.205) were used to calculate the amount of Potassium Carbonate necessary for
the next steps of synthesis. Approximately 6.70 g of K2CO3 was added to a 500 mL RBF with
8.0190 g of 1-methylethoxypyrrolidinium. The reaction was left to stir at 600 RPM on heat at 40°C
for 1 hour. Approximately 50 mL of methanol was added to the RBF for stirring purposes. Vacuum
filtration was used again to filter out and discard the solid KCl waste in order to obtain pure 1methylethoxypyrrolidinium bicarbonate. The solution was again placed on the rotary evaporator
at 15 mbar for 1 hour to evaporate the methanol out of the solution. 4.6292 g of Pyrrolidinium
Bicarbonate was recovered. It is worth mentioning the solution was quite viscous after rotovapping so it is likely some Pyrrolidinium Bicarbonate was lost in the transfer to the storage scint
vial. A new NMR was obtained in order to confirm proper synthesis occurred before moving on
to future synthesis steps. Furthermore, a silver nitrate test was performed to confirm all potassium
chloride waste had been discarded from the solution. Again, molar masses for Pyrrolidinium
Bicarbonate (MW: 190.219 g/mol) and 2-Octenoic acid (MW: 142.20 g/mol) were used in a (1:2)
ratio in order to determine how much of each component to combine. A hot oil bath was heated to
50°C and the stir plate was set to 400 RPM. 3.7630 g of 2-Octenoic acid were added to a 500 mL
RBF, then 2.6280 g of Pyrrolidinium Bicarbonate were added dropwise to the RBF. Less than 1
mL of milli-Q water was used to rinse the master pipette and weighing materials, the milli-Q was
then added to the RBF. The reaction was left to stir on heat overnight for approximately 24 hours.
After 24 hours, the reaction was taken off heat and stir. The solution was then placed on the rotaryevaporator instrument and set to 15 mbar for just over 1 hour in order to evaporate any remaining
solvents in the solution. The mass of the final product was weighed and noted; 4.8438g of
[1MEPY:2OC] were obtained. The solution was then placed in the vacuum oven set at 60°C for
over 48 hours with the top left off. Time sensitivity during this step was not as imperative as other
steps since the purpose of this step was to dry out any remaining solvents or water in the IL. Once
removed from the vacuum oven, the solution was reweighed and an NMR was obtained for
characterization purposes. The final mass of [1MEPY:2OC] being 4.7585g, resulting in a total
percent yield of 87.687%. 1H NMR (400 MHz, DMSO) δ 6.70 (m, 2H), 5.74 (t, J = 12.6 Hz, 2H),
3.83 (t, J = 5.3 Hz, 2H), 3.59 (dd, J = 7.4, 3.5 Hz, 4H), 3.54 (m, 2H), 3.11 (d, J = 5.1 Hz, 3H), 2.18
(m, 8H), 1.44 (m, 4H), 1.29 (m, 8H), 0.82 (dt, J = 11.9, 6.5 Hz, 6H).
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[1PY:2OC] - (1:2) Pyridinium 2-Octenoate Synthesis

Figure 13 - Chemical reactions in the synthesis of [1PY:2OC].

An oil bath was heated to approximately 90°C and the stirrer on the hot plate was adjusted
to 310 RPM. 23.2498 g of pyridine (MW: 79.10 g/mol) were weighed and placed in a 500 mL 3mouthed RBF. 27.3024 g of 2-Chloroethanol (MW: 80.51 g/mol) were weighed and added to the
RBF in a drop-wise manner using the glass pasteur pipette. For this reaction, a condenser was
attached to one opening of the RBF while a gas ventilator was attached to the other opening. The
mixture was left stirring on heat, under the condenser and for approximately 72 hours. After 72
hours, the heat was removed and the solution had turned a cloudy, off-white, solidified or jellylike substance. An NMR was obtained to ensure proper synthesis occurred. Scint vials were pre
weighed in order to store the 1-ethoxypyridinium, and 41.9529g of solution were obtained. Molar
masses for 1-ethoxypyridinium (MW: 159.609 g/mol) and K2CO3 (MW: 138.205) were used to
calculate the amount of potassium carbonate necessary for the next steps of synthesis. 14.0090 g
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of K2CO3 was added to a 500 mL RBF with 16.2986 g of 1-ethoxypyridinium. The reaction was
left to stir at 400 RPM on heat at 35°C for 40 minutes. Approximately 80 mL of methanol was
added to the RBF for stirring purposes. It is worth mentioning that the solution turned a vibrant
orange-yellow color once the reaction had been sitting for 5 minutes; it turned a dark orange
roughly 20 minutes in. Vacuum filtration was used to filter out and discard the solid KCl waste in
order to obtain pure Pyridinium Bicarbonate. The solution was placed on the rotary evaporator at
15 mbar for 1 hour to evaporate the methanol out of the solution. 11.8297 g of pyridinium
bicarbonate was recovered. Furthermore, once the solution came off the rotary evaporator, it had
turned a dark orange-red color and solidified in its storage container. A new NMR was obtained
in order to confirm proper synthesis occurred before moving on to future synthesis steps.
Furthermore, a silver nitrate test was performed to confirm all potassium chloride waste had been
discarded from the solution. Again, molar masses for pyridinium bicarbonate (MW: 184.171
g/mol) and 2-Octenoic acid (MW: 142.20 g/mol) were used in a (1:2) ratio in order to determine
how much of each component to combine. A hot oil bath was heated to 50°C and the stir plate was
set to 400 RPM. 2.9437 g of pyrrolidinium bicarbonate were added to a 500 mL RBF, then 3.9329
g of 2-Octenoic acid were added dropwise to the RBF. Less than 1 mL of milli-Q water was used
to rinse the pasteur pipette and weighing materials, the milli-Q was then added to the RBF. The
reaction was left to stir on heat overnight for just over 24 hours. After 24 hours, the reaction was
taken off heat and stir. The solution was then placed on the rotary-evaporator and set to 15 mbar
for just over 1 hour in order to evaporate any remaining solvents in the solution. The mass of the
final product was weighed and noted; 5.5136g of [1PY:2OC] were obtained. The solution was then
placed in the vacuum oven set at 60°C for over 48 hours with the top left off. Time sensitivity
during this step was not as imperative as other steps since the purpose of this step was to dry out
any remaining solvents or water in the IL. Once removed from the vacuum oven, the solution was
reweighed and an NMR was obtained for characterization purposes. The final visible color for
[1PY:2OC] was a light brown or coffee color. The final mass of [1PY:2OC] being 5.3142g,
resulting in a total percent yield of 88.55%. 1H NMR (400 MHz, DMSO) δ 9.17 (s, 2H), 8.16 (s,
1H), 6.83 (m, 2H), 5.74 (d, J = 15.7 Hz, 2H), 4.79 (s, 2H), 3.87 (s, 2H), 2.12 (s, 4H), 1.37 (s, 4H),
1.23 (s, 8H), 0.83 (s, 6H).
[1MEMO:2OC] - (1:2) 4-methylmorpholine 2-Octenoate Synthesis
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Figure 14 - Chemical reactions in the synthesis of [1MEMO:2OC].

An oil bath was heated to approximately 90°C and the stirrer on the hot plate was adjusted
to 340 RPM. 24.554 g of 4-methylmorpholine (MW: 101.15 g/mol) were weighed and placed in a
500 mL 3-mouthed RBF. 19.5489 g of 2-Chloroethanol (MW: 80.51 g/mol) were weighed and
added to the RBF in a drop-wise manner using the glass pasteur pipette. For this reaction, a
condenser was attached to one opening of the RBF while a gas ventilator was attached to the other
opening. The mixture was left stirring on heat, under the condenser and for approximately 96 hours
(4 days). After 96 hours, the heat was removed and the solution was immediately washed with ~80
mL of acetone due to the solution being highly hygroscopic. 80 mL acetone washing was repeated
3 times with the final washing occurring overnight for 24 hours with a stir bar and on 500 RPM
stir and reflux. After 24 hours of acetone washing, the acetone was discarded and the product was
obtained using gravity filtration. It is essential to work very quickly as the solution is highly
hygroscopic; being left in open air for too long will cause water to aggregate in the solution. The
product was measured and 30.0708 g of 4-methyl-ethyl morpholinium were obtained. After
weighing, the solution was placed in the oven vacuum open vial for over 48 hours at 60°C to ensure
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no remaining acetone was left in the product. Once removed from the oven, an NMR was obtained
to ensure proper synthesis occurred. The solution was stored in the freezer due to its hygroscopic
nature. Molar masses for 4-methyl-ethyl morpholinium (MW: 181.67 g/mol) and KHCO3 (MW:
100.12 g/mol) were used to calculate the amount of potassium bicarbonate necessary for the next
steps of synthesis. 0.6894 g of KHCO3 was added to a 100 mL RBF with 1.2225 g of 4-methylethyl morpholinium. 50 mL of methanol were added to the 100 mL RBF for stirring purposes. The
reaction was left to stir at 250 RPM on heat at 55°C for 24 hours. Vacuum filtration was used to
filter out and discard the solid KCl waste in order to obtain pure 4-methyl-ethyl morpholinium
bicarbonate. The solution was placed on the rotary evaporator at 15 mbar for 1 hour to evaporate
the methanol solvent out of the solution. Once removed from the rotary evaporator, the solution
was reweighed and a new NMR was obtained. 2.4634 g of 4-methyl-ethyl morpholinium
bicarbonate was recovered. A new NMR was obtained in order to confirm proper synthesis
occurred before moving on to future synthesis steps. Furthermore, a silver nitrate test was
performed to confirm all potassium chloride waste had been discarded from the solution. Again,
molar masses for 4-methyl-ethyl morpholinium bicarbonate (MW: 191.22 g/mol) and 2-Octenoic
acid (MW: 142.20 g/mol) were used in a (1:2) ratio in order to determine how much of each
component to combine. A hot oil bath was heated to 90°C and the stir plate was set to 400 RPM.
2.4012 g of 4-methyl-ethyl morpholinium bicarbonate were added to a 500 mL RBF, then 3.347 g
of 2-Octenoic acid were added dropwise to the RBF. Less than 1 mL of milli-Q water was used to
rinse the pasteur pipette and weighing materials, the milli-Q was then added to the RBF. The
reaction was left to stir on heat overnight for approximately 27 hours. After 27 hours, the reaction
was taken off heat and stir then placed on the rotary-evaporator for just over 1 hour at 15 mbar in
order to evaporate any remaining solvents in the solution. The mass of the final product was
weighed and noted; 3.3419 g of [1MEMO:2OC] were obtained. The solution was then placed in
the vacuum oven set at 60°C for over 48 hours with the top left off. Time sensitivity during this
step was not as imperative as other steps since the purpose of this step was to dry out any remaining
solvents or water in the IL. Once removed from the vacuum oven, the solution was reweighed and
an NMR was obtained for characterization purposes. The final mass of [1MEMO:2OC] being
3.215 g, resulting in a total percent yield of 74.91%. 1H NMR (400 MHz, DMSO) δ 6.75 (dt, J =
15.8, 6.9 Hz, 2H), 5.76 (dd, J = 15.5, 1.6 Hz, 2H), 3.93 (t, J = 4.9 Hz, 4H), 3.88 (t, J = 4.9 Hz, 2H),
3.66 – 3.60 (m, 2H), 3.56 (dt, J = 10.9, 5.3 Hz, 2H), 3.48 (dt, J = 8.6, 4.5 Hz, 4H), 3.25 (s, 3H),
2.19 – 2.09 (m, 4H), 1.41 (d, J = 7.2 Hz, 2H), 1.37 (d, J = 7.1 Hz, 4H), 1.26 (dqt, J = 8.1, 5.2, 3.0
Hz, 8H), 0.86 (t, J = 6.8 Hz, 6H).
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Chapter 2: Results and Discussion
Porcine Skin Permeability Tests
In order to determine which anionic component had a higher delivery efficacy through the skin,
and thus should be incorporated as the anion of each future IL synthesized, ex vivo porcine skin
tests were conducted. Rhodamine labeled dextran (10,000 Da MW) was dissolved at a
concentration of 1 mg/mL into choline trans-2-hexenoate (1:2), choline trans-2-octenoate (1:2),
and Phosphate Buffered Saline (PBS) as a control. It is important to note the data obtained for the
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choline 2-octenoate data was collected by another member of the Tanner Lab Research group,
Isabel Nichols. Prior to the porcine skin tests, a calibration curve was created by measuring a set
of serially diluted samples with a fluorescent plate reader with excitation/emission wavelengths of
570/590 nm (Figure 15).

Figure 15 - Calibration curve for 100% PBS standard without any IL. The slope of the calibration curve
was 2.0E8 with an R2 value being near 1 (>0.9999). The R2 value is important to the data set as it represents
how closely the trend-line matches the data.

300 uL of each formulation described above was then placed onto the skin in triplicate and left for
24 hrs at 37 °C. The porcine skin was then sectioned into three layers to test for permeability of
solution: Stratum Corneum (SC), Epidermis (E), and Dermis (D). The acceptor fluid (A) is the
fluid found beneath the porcine skin within the Franz diffusion cell. The purpose of having an
acceptor fluid bar represented in the data is to display how much IL penetrated completely through
all layers of the skin. Each layer of skin was incubated with 3 mL of 50% methanol/PBS on a
shaker overnight. The supernatant of each vial was then analyzed by fluorescent plate reader to
determine the amount of rhodamine-dextran in each layer (Figure 15). The exact protocols for the
ex vivo porcine skin experiments can be found in the appendix of this report.
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Figure 16 - Analyzed data from the 100% IL transport through porcine skin test. Error bars are indicative
of error occurring at 5% level. Blue bars represent 100% trans-2-hexenoate, and red bars represent 100%
2-octenoate. Black bars represent 100% PBS Standard. All porcine testing was done in replicates of 3 (n=3).

Figure 16 shows that the choline 2-octenoate yielded the highest fluorescence in all three layers of
porcine skin; the fluorescence level was significantly higher than the fluorescence level for the
PBS standard. Choline 2-hexenoate yielded lower fluorescence levels in all three layers of skin
than the PBS standard, indicating that choline 2-hexenoate is not a good candidate for improving
permeability through porcine skin. It is because of the low permeability found in 2-hexenoate that
2-octenoate was used as the anion of choice for subsequent IL synthesis. Interestingly enough, the
larger hydrophobic anion yielded a higher fluorescence than the smaller hydrophobic anion. In
general, most of the IL was found in the epidermis, followed by the stratum corneum, dermis, then
the acceptor. This is likely a result of the mechanisms of action for both ILs involved since
hydrophobic fatty acid tails of anions play significant roles in the fluidization of the stratum
corneum lipids. Unsaturation plays a vital role in determining IL or drug delivery efficacy.
However, since both anions involved are unsaturated, hydrophobicity is the key chemical property
examined here. This suggests that since 2-octenoate has a longer fatty-acid chain than trans-2-
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hexenoate, it has a higher hydrophobicity, more efficient mode of lipid disruption, and therefore
highest effective IL permeability in porcine skin (30). Once it was determined that 2-octenoate led
to the highest delivery efficacy through porcine skin, further experimentation into the effects of
tailoring the cationic component of ILs was examined, as 2-octenoate was the anion of choice for
further IL synthesis.

IL Synthesis
[1CA:3PE] - (1:2) choline 3-pentenoate
[1CA:3PE] was synthesized with the intention of being used for non-invasive transdermal delivery.
Literary research has proven choline bicarbonate or other choline derivatized cationic components
to show promising growth to the field of non-invasive medicinal transdermal delivery (19).
Choline bicarbonate has specifically been shown to facilitate transdermal permeation of insulin for
the treatment of Diabetes Mellitus therefore controlling hyperglycemia in patients suffering from
Type-I Diabetes (18). By changing the length of the carbon chain in the anionic component of the
IL, one is better able to understand its effect on the facilitation of transdermal permeation.
This IL was synthesized via a salt metathesis reaction between choline bicarbonate and 3-pentenoic
acid to yield a light yellow, viscous liquid. After being dried to remove as much residual water as
possible, the IL was characterized by 1H NMR spectroscopy (Figure 17). Figure 17 confirms the
successful synthesis of the IL, with peaks labeled 1 - 3 corresponding to the choline cation and
peaks A – D to the 3-pentenoate anion. Note that peaks B and C indicate the presence of a double
bond. By comparing the integrals of peak 1 to peak A, we can confirm that this IL was made in a
ratio of 1:2 cation to anion.
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Figure 17 - NMR spectrum of [1CA:3PE].

Given previous literature findings, one would assume using 3-pentenoate as the anionic component
of IL would hinder penetration through porcine skin due to its lower hydrophobicity. However,
more investigation with actual porcine skin tests would be necessary to finalize this theory.

[1CA:2HE] - (1:2) choline trans-2-hexenoate and [1CA:2OC] - (1:2) choline 2-octenoate
[1CA:2HE] and [1CA:2OC] were synthesized primarily to test their effects on transdermal
permeation, and to determine which anionic component to use for the synthesis of all seven ILs.
Further explanation for the latter purpose can be found in the discussion portion under the porcine
skin test trials. Trans-2-hexenoate and trans-2-Octenoate were, separately, combined with choline
bicarbonate in a (1:2) ratio of choline:anion in order to test their facilitation with transdermal
permeation of porcine skin. This transdermal delivery test primarily served the purpose of
determining which anionic component to continue with in the formation of the latter ILs
synthesized throughout this research. Choline bicarbonate was the constant factor between these
two ILs as the anionic component was the variable factor.
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These ILs were synthesized via a salt metathesis reaction between choline bicarbonate and X-anion
acid. [1CA:2HE] reacted choline bicarbonate with six-carbon trans-2-hexenoate whereas
[1CA:2OC] reacted choline bicarbonate with eight-carbon 2-octenoate. Each reaction yielded a
transparent yellow, viscous liquid. After being dried to remove as much residual water as possible,
each IL was characterized by 1H NMR spectroscopy (Figures 18 and 19). Figure 18 confirms the
successful synthesis of [1CA:2HE], with peaks labeled 1 - 3 corresponding to the choline cation
and peaks A – E to the trans-2-hexenoate anion. Note that peaks D and E indicate the presence of
a double bond. By comparing the integrals of peak 1 to peak A, we can confirm that this IL was
made in a ratio of 1:2 cation to anion. Similarly, figure 19 confirms the successful synthesis of
[1CA:2OC] with peaks labeled 1 - 3 corresponding to the choline cation and peaks A – F to the 2octenoate anion. Note that peaks E and F indicate the presence of a double bond with this IL. By
comparing the integrals of peak 1 to peak A, we can confirm that this IL was made in a ratio of
1:2 cation to anion.

Figure 18 - NMR spectrum of [1CA:2HE].
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Figure 19 - NMR spectrum of [1CA:2OC].

Both [1CA:2HE] and [1CA:2OC] were diluted to a 25% concentration level and, following
predetermined protocols, were tested on porcine skin in order to determine the effect of carbon
chain length on permeability. It was discovered that both ILs had a tendency to get stuck in the
epidermal layer of the skin, with a lower concentration being found in the dermal portion of the
skin. However, in all 4 divisions of porcine skin tested on, 2-octenoate had a higher concentration
than trans-2-hexenoate and the PBS standard. This is likely due to 2-octenoate having a higher
hydrophobicity and therefore higher delivery efficacy. It is for this reason that 2-octenoic acid was
the anion of choice in all further IL synthesis reactions.

[1MEIM:2OC] - (1:2) 1-methylimidazolium 2-octenoate
In order to examine the effect of delocalization of the cation in a ring structure, [1MEIM:2OC]
was synthesized. Methyl-imidazole was chosen for the cationic component for the purpose of
undergoing a quaternization reaction with 2-chloroethanol. The product from this reaction being
1-methyl ethoxy imidazolium with Chloride ions as a byproduct. The next step in this synthesis is
a salt metathesis reaction in order to swap potassium bicarbonate with the chloride ion halides
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found in the solution thus yielding 1-methyl ethoxy imidazolium bicarbonate. In doing so,
potassium chloride and carbonate were formed, and potassium chloride was discarded from the
solution via vacuum filtration. The last step is also a salt metathesis reaction performed to dispose
of the bicarbonate in solution via carbon dioxide and water waste products. The final reaction
resulted in the formation of [1MEIM:2OC].
This IL was synthesized via a salt metathesis reaction between methylimidazolium and 2-octenoic
acid to yield a light brown, viscous liquid. After being dried to remove as much residual water as
possible, the IL was characterized by 1H NMR spectroscopy (Figure 20). Figure 20 confirms the
successful synthesis of the IL, with peaks labeled 1 - 5 corresponding to the methylimidazolium
cation and peaks A – E to the 2-octenoate anion. Note that peaks D and E indicate the presence of
a double bond with this IL. Peak 2 is split by a double bond between two identical carbon atoms,
and peak 5 is indicative of a double bonded carbon connected to a nitrogen atom. Peak 5 is more
deshielded which is why it is found further downfield on the spectra. Peaks 3 and 4 look similar in
size because they each contain a -CH2 group from the ethoxy side chain of the cation. Peak 3 is
more deshielded which is why it can be found further downfield on the NMR spectra as a result.
Peak 1 is indicative of one methyl group whereas peak A indicates 2 -CH3 groups. By comparing
the integrals of the peak 1 to peak A, we can confirm that this IL was made in a ratio of 1:2 cation
to anion.
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Figure 20 - NMR spectrum of [1MEIM:2OC].

There were three solvent peaks found in the NMR data for [1MEIM:2OC] which are displayed on
the NMR: 1.38 ppm, 1.79 ppm, and 2.69 ppm. At 1.38 ppm the solvent peak is likely n-butanol
(10). At 1.79 the solvent peak is likely 2-methyl tetrahydrofuran (10). At 2.69 ppm the solvent
peak is likely water (10).

[1MEPY:2OC] - (1:2) 1-methylpyrrolidinium 2-octenoate
In order to examine the effect of a 5-carbon ring structure without delocalization in the cationic
component of the IL, [1MEPY:2OC] was synthesized. Methyl-pyrrolidinium was also chosen for
the cationic component with the purpose of undergoing a quaternization reaction with 2chloroethanol. The product from this quaternization reaction being 1-methyl ethoxy pyrrolidinium
with Chloride ion as a byproduct. The next step in the synthesis of [1MEPY:2OC] was a salt
metathesis reaction in which potassium bicarbonate was swapped with the chloride halide ion
found in the solution. The products of this double displacement include 1-methyl ethoxy
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pyrrolidinium, potassium chloride, and carbonate. The waste product being potassium chloride
which was discarded appropriately via vacuum filtration. 1-methylethoxypyrrolidinium
bicarbonate was further combined with 2-octenoate in a (1:2) ratio via another salt metathesis
reaction. The purpose of this final step was to discard any bicarbonate still left in solution in the
form of carbon dioxide and water as waste.
This IL was synthesized via a salt metathesis reaction between methylpyrrolidinium and 2octenoic acid to yield a viscous liquid with a transparent, clear color. After being dried to remove
as much residual water as possible, the IL was characterized by 1H NMR spectroscopy (Figure
21). Figure 21 confirms the successful synthesis of the IL, with peaks labeled 1 - 5 corresponding
to the methylpyrrolidinium cation and peaks A – E to the 2-octenoate anion. Note that peaks D
and E indicate the presence of a double bond within the anionic component. Furthermore, there
are no peaks signaling a double bond within the cationic component. Peaks 2 and 3 are both split
by two identical carbon groups in each. Peak 2 is located further downfield due to its connectivity
to a nitrogen atom within a 5-carbon ring structure. Peak 1 is indicative of one methyl group
whereas peak A indicates 2 -CH3 groups. Therefore, by comparing the integrals of the methyl
group in peak 1 to peak A, we can confirm that this IL was made in a ratio of 1:2 cation to anion.
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Figure 21 - NMR spectrum of [1MEPY:2OC].

[1PY:2OC] - (1:2) pyridinium:2-octenoate
In order to assess the effects of aromaticity in the cationic component of the IL, [1PY:2OC] was
synthesized. Pyridine was first combined with 2-chloroethanol in order to alkylate the nitrogen
atom thus resulting in an ethoxy alkyl chain on the nitrogen atom of pyridine with chloride ion as
a byproduct. Potassium bicarbonate was then added to the pyridine ethoxy chain in proper molar
ratios in order to undergo a salt metathesis reaction thus leaving potassium chloride and carbonate
as waste products. Before further synthesis, the potassium chloride was discarded via vacuum
filtration. Pyridine bicarbonate was then combined with 2-Octenoic acid in a (1:2) ratio via
another salt metathesis reaction thus resulting in the product of [1PY:2OC] with carbon dioxide
and water as waste products.
This IL was synthesized via a salt metathesis reaction between pyridine and 2-octenoic acid to
yield a highly viscous liquid with a dark brown color. After being dried to remove as much residual
water as possible, the IL was characterized by 1H NMR spectroscopy (Figure 22). Figure 22
confirms the successful synthesis of the IL, with peaks labeled 1 - 5 corresponding to the aromatic
pyridine cation and peaks A – E to the 2-octenoate anion. Note that peaks D and E indicate the
presence of a double bond. Peaks 1 through 3 also indicate the presence of double bonds in the
form of an aromatic ring structure. Peaks 2 and 3 both are split by identical 2 carbon atoms and a
double bond. Peak 3 is located further downfield due to its connectivity to a nitrogen atom.
Although peak 1 can be found in the aromatic portion of the cationic component, it does not have
an identical signal, like peak 2 or 3, which is why it only contains one carbon atom. Peaks 4 and 5
look similar in size because they each contain a -CH2 group. Peak 4 is found further downfield
because it is connected to the nitrogen atom within the ethoxy side-chain of pyridine. By
comparing the integrals of peaks 2, and 3 to peaks A and B, we can confirm that this IL was made
in a ratio of 1:2 cation to anion.
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Figure 22 - NMR spectrum of [1PY:2OC].

[1MEMO:2OC] - (1:2) 4-methylmorpholine:2-octenoate
In order to examine the effects that both Oxygen and Nitrogen atoms have on a molecule when
found in a ring structure together, [1MEMO:2OC] was synthesized. The intent was to examine
how oxygenation of the cationic component affects the IL as a whole. Initially, 4methylmorpholine was combined with 2-chloroethanol thus taking an aliphatic tertiary amine and
oxidizing it through a quaternization reaction. The product of this initial reaction includes 4methylethoxymorpholine with a chloride ion halide as a byproduct. Molar masses were used to
calculate how much potassium bicarbonate was necessary in order to fully exchange the chloride
ion with potassium bicarbonate in a salt metathesis reaction. Byproducts of this first salt metathesis
reaction include potassium chloride and carbonate. Potassium chloride was properly disposed of
via vacuum filtration. 4-methylethoxymorpholinium bicarbonate was then combined with 2Octenoic acid in a (1:2) ratio in a salt metathesis reaction thus allowing the bicarbonate ions to be
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eliminated from the solution in the form of carbon dioxide and water. The final product
[1MEMO:2OC] was left as a result.
This IL was synthesized via a salt metathesis reaction between 4-methylmorpholine and 2-octenoic
acid to yield a transparent yellow, viscous liquid. After being dried to remove as much residual
water as possible, the IL was characterized by 1H NMR spectroscopy (Figure 23). Figure 23
confirms the successful synthesis of the IL, with peaks labeled 1 - 5 corresponding to the 4methylmorpholine cation and peaks A – F to the 2-octenoate anion. Note that peaks E and F
indicate the presence of a double bond in the anionic component. Peaks 4 and 5 are both split by
2 carbon atoms with two identical signals each. Peak 5 is located further downstream because it is
connected to an oxygen atom within a ring structure. Peaks 2 and 3 look similar in size because
they each contain a -CH2 group. However, peak 3 is found further downfield because it is
connected to the nitrogen atom within the ethoxy side-chain of 4-methylmorpholine. Peak 1 is
indicative of one methyl group whereas peak A indicates 2 -CH3 groups. Thus, by comparing the
integrals of peak 1 to peak A, we can confirm that this IL was made in a ratio of 1:2 cation to
anion.

Figure 23 - NMR spectrum of [1MEMO:2OC].
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The final product of [1MEMO:2OC] contained 2 solvent peaks as found in the NMR data. The
solvent peak found at 1.41 ppm is likely cyclohexane or n-butanol, whereas the solvent peak found
at 3.56 ppm is likely 2-methyl tetrahydrofuran (10).
The effects of tailoring different cationic components for IL synthesis on drug delivery efficacy is
severely lacking in the literature. The research achieved here explains the step-by-step methods
for synthesizing and characterizing ILs using choline bicarbonate, methylimidazolium,
methylpyrrolidinium, pyridine, and methylmorpholinium as cationic components. Further
investigation in porcine skin testing would be necessary to accurately assess the effects of differing
nitrogen-based cationic components in ILs for drug delivery efficacy purposes.
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Chapter 3: Forensic Application
Ionic liquids are a growing category of solvents in many scientific, industrial, medical,
environmental, biological, and molecular fields. Recent studies have proven Ionic Liquids to be
an especially increasing trend for forensic science investigations, techniques, and methods (9, 12,
13, 14, 16, 22, 24). The requirements for separation, extraction, and preconcentration procedures
have undergone numerous changes and improvements in recent years, yet complex sample and
trace concentrations of low-dose legal and illegal drugs present issues for forensic toxicologists
and scientists (22). In many chemical fields, thorough sample preparation is necessary for accurate
and reliable analysis. Ionic liquids are of such interest to forensic fields because they fall under the
category of green or sustainable chemistry which focuses on the design of products and processes
that minimize or eliminate the use and generation of hazardous substances (22).
Microextraction processes have been employed by forensic scientists for many years
because it tends to avoid the use of large solvent volumes while still obtaining high analyte
enrichment. Generally, the trend has been to increase the analytical performance of extraction or
microextraction techniques while also satisfying the requirements of green or sustainable
chemistry (14). An increasing trend in forensics is the search for alternative nonmolecular solvents,
such as ionic liquids, to replace toxic and volatile organic solvents. In this context, ILs have been
utilized with microextraction procedures in order to follow the current trends (14). In recent years,
Ionic Liquids and Polymeric Ionic Liquids (PILs) have been used in a Single-Drop Microextraction
(SDM), a Liquid-Phase Microextraction (LPM), a Solid-Phase Microextraction (SPME), a
Dispersive Liquid-Liquid Microextraction (DLLME), a Hollow Fiber-Supported Liquid
Membrane Extraction (HFSLME) and in a Solid Phase Extraction (SPE) (24). ILs are thought to
be promising alternatives due to their diverse chemical properties: low melting temperature, low
volatility, negligible vapor pressure, low flammability, and good thermal and chemical stability
(22). Ionic liquids are versatile in that their chemical structure can be drastically altered by simply
changing the cationic or anionic component of the molecule or by incorporating specific functional
groups in the molecule. This results in an optimization of physicochemical properties for the
extraction of specific analytes due to ionic liquid application (14). In forensic applications, careful
engineering of the IL structure has given rise to innovative DNA extraction systems, ion
conductive DNA films, and DNA preservation media (13). This section discusses the application
of ionic liquids in forensic fields especially in regards to hydrophobic MIL synthesis, high
throughput nucleic acid analysis, time-consuming sample preparation, new and efficient DNA

45

extraction methods, and separation technology (9, 12, 13, 14, 16, 22, 24).
In one study, magnetic ionic liquids have been used as polymerase chain reactioncompatible solvents for DNA extraction from biological samples (13). PCR buffers have been
systematically designed to relieve the inhibition caused by hydrophobic magnetic ionic liquids
(MILs) thus allowing DNA extraction from bacterial cell lysate. Clinical diagnostics, food and
drug safety, genomics, and microbiology are a few of the many fields in which nucleic acid
analysis is growing (13). PCR and sequencing methods are capable of selectively detecting very
small quantities of nucleic acids which is why they are of the utmost importance for forensic
casework. However, traditional techniques are limited by their low tolerance to interfering
constituents found within complex biological or environmental sample matrices (13).
Consequently, the isolation of adequately purified nucleic acids often requires numerous timeconsuming sample preparation steps. In an effort to increase sample throughput and minimize user
interferences, magnetic-based IL approaches have become particularly attractive methods that
utilize magnetoactive sorbents to rapidly extract and manipulate nucleic acid samples (13).
Pathogen detection, forensics, drug discovery and applications, and genomic studies are some
areas where functionalized magnetic particles have been explored as a means to drastically reduce
the overall analysis time. Magnetic Ionic liquid (MIL) solvents offer a promising new magneticbased approach for the selective analysis of nucleic acids because of their unique physicochemical
properties and controllability in regards to tailoring the cationic or anionic component (13). The
difference between MILs and ILs is that MILs exhibit paramagnetic behavior in an applied external
magnetic field. Traditional ILs have been successfully applied as sorptive phases for DNA, nucleic
acid and preservation media, and PCR media (13). However, hydrophobic MILs have only recently
been reported as solvents capable of performing highly efficient DNA extractions and
microextractions from aqueous solutions. A typical hydrophobic MIL often consists of a cationic
component containing long alkyl chains and/or aromatic moieties, as well as a transition metalbased anionic component (24). The results of this study focused on using either
trihexyl(tetradecyl)- phosphonium tetrachloroferrate(III) ([P+][FeCl−]) MIL or the
trioctylbenzylammonium bromotrichloroferrate(III) ([(C8)3BnN+][FeCl3Br−]) MIL to demonstrate
the applicability of MIL extraction solvents with biochemical assays to achieve rapid and efficient
enrichment for the analysis of DNA and biological materials (13). Furthermore, it was discovered
that any PCR inhibition caused by the cationic or anionic components of the two studied MILs
could be mitigated using albumin, iron (III) chelation, and by increased buffer capacity of the PCR
mixture (13). This study focused on showing how MILs were not only capable of extracting PCR
amplifiable DNA from unprocessed bacterial cell lysate, but also how MILs were capable of doing

46

so rapidly with a non-time-consuming sample preparation and purification for DNA recovery
procedures. Finally, this study demonstrated the compatibility of MIL solvents with bioanalytical
techniques to dramatically reduce the time required for DNA analysis, making MILs particularly
attractive for food safety or other high throughput applications.

Figure 24 - Chemical structures of a) [P6,6,6,14+][FeCl4−] and b) [(C8)3BnN+][FeCl3Br−] MILs.

The development of magnetic Ionic Liquid solvents for analytical extractions has the
potential to thoroughly impact nucleic acid analysis by combining the tunability of the IL with the
magnetic nature of the solvent used. In another study, three different hydrophobic magnetic ionic
liquids (MILs) were synthesized and employed as viable solvents for the rapid and efficient
extraction of DNA from aqueous solution (12). Furthermore, the ability to personally tailor the IL
structure to achieve favorable electrostatic interactions with the phosphate backbone of DNA
molecules thus adequately provides enhanced extraction efficiency as well as significantly reduced
sample preparation for the recovery of DNA-enriched extractions (12). This study honed in on the
ability to magnetically manipulate ILs for downstream analysis such as injection into microfluidic
devices. The three MILs synthesized were 1,12-bis[N-(N′-hexadecylbenzimidazolium)-dodecanebis[(trifluoromethyl)sulfonyl]imide-bromotrichloferrate(III)
([(C16BnIM)2C122+][NTf2,FeCl3Br−]), benzyltrioctylammonium bromotrichloroferrate-(III) ([(C8)3BnN+][FeCl3Br−]), and
trihexyl(tetradecyl)-phosphonium tetrachloroferrate(III) ([P6,6,6,14+][FeCl4−]) (12). The three MILs
examined in this study exhibited unique DNA extraction capabilities when applied towards a
variety of DNA samples and matrices. High extraction efficiencies were obtained for smaller
single-stranded and double-stranded DNA using ([(C8)3BnN+][FeCl3Br−]) MIL, while
([(C16BnIM)2C122+][NTf2-, FeCl3Br−]) MIL produced higher extraction efficiencies for larger DNA
molecules (12). The hydrophobic MIL-based method was also employed for the extraction of DNA
from a complex matrix containing albumin, revealing a competitive extraction behavior for
([P6,6,6,14+][FeCl4−]) in contrast to [(C8)3BnN+][FeCl3Br−], which resulted in significantly less co-
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extraction of albumin (12). The MIL-DNA method was employed for the extraction of plasmid
DNA from bacterial cell lysate, similarly to the first study. Overall, the applicability and timeliness
of MIL-based DNA sample preparation prior to analysis was further demonstrated in this study,
while DNA of sufficient quality and quantity for PCR amplification was recovered from the MIL
extraction phase.
In congruence with the diversity and realm of applications for ionic liquids, ILs have
recently been applied to separation technology. Because they are so versatile and can be composed
from numerous, variable cationic and anionic components, ILs have been applied in different areas
of separation such as IL supported membranes, mobile phase additive, surface-bonded stationary
phases in chromatography separations, and as the extraction solvent in sample preparation (16). In
regards to separation techniques and technology, alkylimidazolium-based ILs have been used as a
stable stationary phase for gas chromatography (16). Alkylimidazolium-based ILs display unusual
selectivity in which they separate polar compounds as if they were polar stationary phases and
nonpolar compounds. This suggests that ILs might be useful in multi-modal media in
chromatographic separations for future application and usage (16). Furthermore, ILs can be used
as mobile phase additives in reversed-phase chromatography when they are mixed with other low
viscosity solvents. Further separation technique IL application includes electrolyte additives,
running buffer modifiers and supported coatings on the capillary walls in capillary electrophoresis
(CE), and more efficient and timely separation techniques in recent years (16). This final study
described the many different applications of ILs in separation technology including: ILs as mobile
phase additives in liquid chromatography, ILs used as extraction solvents in sample preparation
techniques, extraction of bioactive compounds in natural plant, ILs used as surface-bonded
stationary phases, IL membranes for the selective transport of organic compounds in preparation
of supported IL membranes, and gas separation by supported IL membranes (16). Overall, there
are many diverse applications of ionic liquids for forensic sciences and studies; this portion of
research only begins to scratch the surface for this growing class of organic solvents.
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Conclusions
The primary focus of this research was to consider and examine the effects of modifying
the cationic component of an ionic liquid on the outcome of the chemical reactions occurring. Each
IL was synthesized in an effort to correlate its physicochemical characteristics and properties to
solubility and permeability in porcine skin through transdermal delivery. The most efficient
methods for IL synthesis were determined through trial-and-error experimentation in an effort to
determine the optimal reaction settings and requirements necessary for each cationic or anionic
component involved. This research was performed in an effort to aid future investigations in
transdermal delivery techniques and permeability, as well as pharmaceutical investigations in
developing more soluble, bioavailable, and metabolically stable active pharmaceutical ingredients
for future medicinal purposes.
The purpose for the porcine skin testing was to determine which anion worked best in
regards to drug delivery efficacy through the dermal layers. It was discovered 2-octenoate led to
the highest percentage of permeability and concentration levels in the dermis of porcine skin which
is why it was the anionic component selected for incorporation in all following ILs synthesized.
After determining 2-octenoate obtained the best results in regards to porcine skin permeability, the
effects of tailoring the cationic components of IL were analyzed.
Chemical properties such as delocalization, non-delocalization, aromaticity, oxidation, and
anionic carbon chain length were examined through the different starting materials of each specific
IL. The cationic components selected to examine previously listed chemical properties include
methyl-imidazolium, methyl-pyrrolidinium, pyridine, and methyl-morpholinium respectively.
In order to ensure proper chemical synthesis had occurred throughout experimentation, 1H
NMR spectra was obtained, characterized, and analyzed. All of the 1H NMR spectra were recorded
in a Bruker Avance III 400 MHz NMR spectrometer (Bruker, Billerica, MA, United States). To
obtain the spectra, a sample of approximately 20 μL was dissolved in 600 μL of DMSO deuterated
solvent using 1H NMR to run the sample for 16 scans. 1H NMR allows the molecular structure of
a material to be analyzed by observing and measuring the interaction of nuclear spins when placed
in a powerful magnetic field (10). The data obtained from the 1H NMR spectra were characterized
and analyzed in a peak-by-peak analytical method to ensure proper synthesis had occurred
throughout experimentation. Furthermore, the moisture or water contents of the ILs were
determined via a biamperometric titration of previously weighed amounts injected into a Karl-
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Fischer’s reaction vessel.
Overall, the effects of tailoring cationic components for ILs were analyzed through unique
synthesis mechanisms while 1H NMR was used to confirm proper chemical reactions had occurred.
The experimentation done in this research is useful for transdermal delivery studies in the hopes
of increasing solubility and medicinal efficiency for both current and future active pharmaceutical
ingredients.
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Appendix
Porcine Skin Test Protocols
A. Preparation of the Diffusion Cells
All workbenches and tools were first sprayed with 70% Ethanol for sanitation purposes. Prior to
beginning, one strip of porcine skin was removed from the -80°C freezer from which it was stored.
It is imperative to allow the skin to thaw fully without disturbing it. A 36 mm hole-punch and a
hammer were used to cut out a thin disk of skin with less visible pores. A scalpel was used to
remove any remaining connective tissues. All hairs or debris were removed from the skin, ensuring
not to cut through the stratum corneum. Each disk was washed with 1 mL PBS Standard and dried
with kimwipes. A stirrer bar was placed in the acceptor chamber of a Franz Diffusion Cell. The
chamber was filled to the top with PBS solution. The disk of skin was placed on top of the acceptor
chamber. A donor chamber was placed on top of the skin, and a clamp was used to seal the skin in
place. Forceps were also used to ensure there were no folds in the skin disk. The chamber was
turned upside down to remove any air bubbles in the side arm. 1 mL of PBS was added to the
donor chamber. The conductivity of the disk was then tested by using a waveform generator and
observing the voltage. All samples with a conductivity reading less than 10 μA were used for
testing. The 1 mL of PBS was removed from the donor chamber and the diffusion cells were placed
in the 37°C oven to heat up. The samples of interest were weighed out and recorded. If necessary,
the sonicator and vortexer were utilized to homogenize the sample. Cells were removed from the
oven and 300 μL of IL-test sample was placed onto the skin ensuring that the whole surface was
covered. The top to the donor chamber was sealed with parafilm followed by foil. And all samples
were labelled appropriately. Lastly, the cells were returned to the 37°C oven for exactly 24 hours.
B. Extraction of the Drug into Methanol/PBS
All workbenches and tools were first sprayed with 70% Ethanol for sanitation purposes. 8 scint
vials were labeled for each sample tested: A, SC, E, D. Acceptor fluid - A1, A2, A3; First Stratum
Corneum Strip - SC1; Stratum Corneum Strips 2 through 5 - SC2, SC3, SC4, SC5; Stratum
Corneum Strips 6 through 10 - SC6, SC7, SC8, SC9, SC10; Epidermis - E; Dermis - D. 3 mL of
50% Methanol/PBS were placed into each scint vial. All tools and workbenches were sprayed with
70% Ethanol between each sample to avoid any cross-contamination. Diffusion cells were
removed from the 37°C oven. The sealant foil and parafilm were also removed. Any leftover
solution from the donor chamber was removed with a pipette. 50 μL of one of the solutions was
collected and placed to the side for later use. The skin was washed with 1 mL PBS solution twice
then dried with a kimwipe. The diffusion cells were disassembled and the skin was placed on a
cutting board, ensuring that the skin disks were dried thoroughly. The acceptor fluid was collected
and distributed into their three respective scint vials. A 15 mm hole-punch and a hammer were
used to remove the central portion of the skin disk. An inch of scotch tape was pressed gently to
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the top of the skin then placed into the scint vial labelled ‘SC1’. The tape stripping was repeated 9
more times and each strip was placed in its respective scint vial: strips 2-5 placed in ‘SC2’-’SC5’,
and strips 6-10 placed in ‘SC6’-’SC10’. The Epidermis was separated from the dermis with a
scalpel and placed in scint vial ‘E’. A 4 mm hole-punch and hammer were used to remove three
circles of the dermis. A scalpel was used to half each of the 3 dermis circled which were then
placed in scint vial ‘D’. All scint vials were capped and placed onto a shaker at RT overnight.
C. Plate Reading
1 mL of the liquids from each sample vial were collected and centrifuged at 14000 g for 5 minutes
in an Eppendorf tube. 250 μL of the liquid sample from the tubes were pipetted into one well of a
black 96 well plate. Standards were prepared to provide a calibration curve using serial dilution.
A SpectraMax Plate reader was used to obtain the raw data. The read height adjustment was run
for each time. The raw data was divided by the gradient of the calibration curve in order to get the
sample concentrations in mg/mL. The concentration was then multiplied by 3 mL to get the mass
in solvent. To get the mass in tissue or acceptor sample, the stratum corneum, epidermis, and
acceptor were all treated the same as the mass in solvent. For the mass in tissue of the dermis, the
mass in solvent was further multiplied by 3 again. To get the transport data (mass/area), all mass
numbers were divided by 1.77 cm2 as this was the area of the 15 mm diameter punch.
D. Finishing Up
All scint vials were disposed of in the solid glassware waste. All stirrer bars were collected and
washed thoroughly with DI water then dried. All diffusion cells were washed thoroughly with
detergent and hot water. Lastly, all diffusion cell pieces were rinsed in DI water and layed in open
air to dry.
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